Clinical Trial Update: A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 clinical study to evaluate the pharmacokinetic and pharmacodynamic properties of SHR-3167 in adults with Type 2 diabetes. The trial is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SHR-3167

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: RECRUITING